Retavase

Active Ingredient(s): Reteplase, r-PA
FDA Approved: * October 30, 1996
Pharm Company: * CENTOCOR INC
Category: Blood Thinner (Anticoagulant)

Reteplase, trade names include Retavase, is a thrombolytic drug, used to treat heart attacks by breaking up the clots that cause them. Reteplase is a recombinant non-glycosylated form of human tissue plasminogen activator, which has been modified to contain 357 of the 527 amino acids of the original protein. It is produced in the bacterium Escherichia coli.[citation needed] Reteplase was approved for use in 1996.[1] Reteplase is similar to recombinant human tis... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Retavase Kit
NDC: 10122-141
Labeler:
Chiesi USA, Inc.
Retavase Kit
NDC: 10122-143
Labeler:
Chiesi USA, Inc.
Retavase Kit
NDC: 24477-040
Labeler:
Ekr Therapeutics, Inc.
Retavase Kit
NDC: 24477-041
Labeler:
Ekr Therapeutics, Inc.